Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
Front Immunol. 2019 Jul 2:10:1523.
doi: 10.3389/fimmu.2019.01523.
eCollection 2019.
1 Clinical Epidemiology Unit, Qilu Hospital of Shandong University, Jinan, China.
2 Key Laboratory of Cancer Prevention and Therapy of Tianjin, Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
3 Key Laboratory of Cancer Prevention and Therapy, Department of Breast Cancer Pathology and Research Laboratory, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
4 Department of Respiratory Medicine, Central Hospital of Zibo, Zibo, China.
5 Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
6 Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
7 Department of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University, Chongqing, China.